Limonard E J, Bisschop P H, Fliers E, Nieveen van Dijkum E J
Department of Surgery, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
ScientificWorldJournal. 2012;2012:548796. doi: 10.1100/2012/548796. Epub 2012 Feb 1.
Subtotal thyroidectomy is a surgical procedure, in which the surgeon leaves a small thyroid remnant in situ to preserve thyroid function, thereby preventing lifelong thyroid hormone supplementation therapy.
To evaluate thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism.
We retrospectively reviewed the medical records of all patients (n = 62) who underwent subtotal thyroidectomy for recurrent Graves' hyperthyroidism between 1992 and 2008 in our hospital. Thyroid function was defined according to plasma TSH and free T4 values.
Median followup after operation was 54.6 months (range 2.1-204.2 months). Only 6% of patients were euthyroid after surgery. The majority of patients (84%) became hypothyroid, whereas 10% of patients had persistent or recurrent hyperthyroidism. Permanent recurrent laryngeal nerve palsy and permanent hypocalcaemia were noted in 1.6% and 3.2% of patients, respectively.
In our series, subtotal thyroidectomy for Graves' hyperthyroidism was associated with a high risk of postoperative hypothyroidism and a smaller, but significant, risk of persistent hyperthyroidism. Our data suggest that subtotal thyroidectomy seems to provide very little advantage over total thyroidectomy in terms of postoperative thyroid function.
甲状腺次全切除术是一种外科手术,术中外科医生会在原位保留一小部分甲状腺组织以维持甲状腺功能,从而避免终身甲状腺激素替代治疗。
评估格雷夫斯甲亢患者行甲状腺次全切除术后的甲状腺功能。
我们回顾性分析了1992年至2008年间在我院因复发性格雷夫斯甲亢接受甲状腺次全切除术的所有患者(n = 62)的病历。根据血浆促甲状腺激素(TSH)和游离甲状腺素(free T4)值定义甲状腺功能。
术后中位随访时间为54.6个月(范围2.1 - 204.2个月)。术后仅6%的患者甲状腺功能正常。大多数患者(84%)出现甲状腺功能减退,而10%的患者存在持续性或复发性甲亢。分别有1.6%和3.2%的患者出现永久性喉返神经麻痹和永久性低钙血症。
在我们的研究系列中,格雷夫斯甲亢患者行甲状腺次全切除术术后甲状腺功能减退风险高,持续性甲亢风险较小但显著。我们的数据表明,就术后甲状腺功能而言,甲状腺次全切除术相比甲状腺全切除术似乎优势甚微。